The NR2B Subtype of NMDA Receptor: A Potential Target for the Treatment of Alcohol Dependence

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|3|3|169-179

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.3, Iss.3, 2004-06, pp. : 169-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NMDA receptor antagonists as analgesics: focus on the NR2B subtype

By Chizh B.A.   Headley P.M.   Tzschentke T.M.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 12, 2001-12 ,pp. : 636-642

Elsevier

Access to resources Recommend Favorite

NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004

By McCauley John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 389-407

Informa Healthcare

Access to resources Recommend Favorite

The NMDA receptor NR2B subtype selective antagonist Ro 25-6981 aggravates paroxysmal dyskinesia in the dt sz mutant

By Richter A.  

European Journal of Pharmacology, Vol. 458, Iss. 1, 2003-01 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 7, 2006-04 ,pp. : 697-709

Bentham Science Publishers

Access to resources Recommend Favorite

NR2B Selective NMDA Receptor Antagonists

By  

Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. : 845-855

Bentham Science Publishers

Access to resources Recommend Favorite